Scarica l'app Stockscreener
27.96
0.21%
-0.06
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché PFE Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$28.02
Aprire:
$28
Volume 24 ore:
27.25M
Relative Volume:
0.66
Capitalizzazione di mercato:
$159.36B
Reddito:
$63.32B
Utile/perdita netta:
$7.52B
Rapporto P/E:
21.44
EPS:
1.3043
Flusso di cassa netto:
$9.48B
1 W Prestazione:
-0.39%
1M Prestazione:
+10.73%
6M Prestazione:
+1.12%
1 anno Prestazione:
+13.66%
Intervallo 1D:
$27.77
$28.02
Intervallo di 1 settimana:
$27.77
$28.58
Portata 52W:
$23.58
$28.75
Pfizer Inc Stock (PFE) Company Profile
Nome
Pfizer Inc
Settore
Industria
Telefono
(212) 733-2323
Indirizzo
66 HUDSON BOULEVARD EAST, NEW YORK, NY
Compare PFE vs LLY, JNJ, ABBV, MRK, NVS
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PFE
Pfizer Inc
|
27.96 | 158.39B | 63.32B | 7.52B | 9.48B | 1.3043 |
LLY
Lilly Eli Co
|
1,174.61 | 1.11T | 72.25B | 25.28B | 10.37B | 27.78 |
JNJ
Johnson Johnson
|
268.04 | 644.33B | 97.93B | 21.04B | 17.80B | 8.6278 |
ABBV
Abbvie Inc
|
255.48 | 462.68B | 62.82B | 3.60B | 19.98B | 2.0274 |
MRK
Merck Co Inc
|
148.35 | 367.58B | 65.51B | 8.93B | 14.12B | 3.5532 |
NVS
Novartis Ag Adr
|
153.81 | 296.97B | 54.66B | 13.58B | 16.05B | 7.0171 |
Pfizer Inc Stock (PFE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-02 | Aggiornamento | Argus | Hold → Buy |
| 2026-02-25 | Iniziato | RBC Capital Mkts | Underperform |
| 2026-02-20 | Iniziato | Barclays | Underweight |
| 2026-02-12 | Downgrade | Daiwa Securities | Outperform → Neutral |
| 2026-01-07 | Ripresa | UBS | Neutral |
| 2025-12-02 | Ripresa | Citigroup | Neutral |
| 2025-11-13 | Iniziato | Scotiabank | Sector Outperform |
| 2025-04-22 | Iniziato | Cantor Fitzgerald | Neutral |
| 2024-12-10 | Ripresa | BofA Securities | Neutral |
| 2024-11-15 | Iniziato | Wolfe Research | Underperform |
| 2024-10-25 | Ripresa | Citigroup | Neutral |
| 2024-10-17 | Iniziato | Bernstein | Mkt Perform |
| 2024-08-07 | Aggiornamento | Daiwa Securities | Neutral → Outperform |
| 2024-03-22 | Downgrade | Argus | Buy → Hold |
| 2024-02-23 | Iniziato | Guggenheim | Buy |
| 2024-01-04 | Downgrade | TD Cowen | Outperform → Market Perform |
| 2023-10-20 | Ripresa | UBS | Neutral |
| 2023-10-16 | Aggiornamento | Jefferies | Hold → Buy |
| 2023-07-17 | Reiterato | JP Morgan | Neutral |
| 2023-07-14 | Iniziato | HSBC Securities | Buy |
| 2023-06-29 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2023-05-11 | Downgrade | Daiwa Securities | Outperform → Neutral |
| 2023-03-06 | Iniziato | Jefferies | Hold |
| 2023-02-07 | Aggiornamento | Daiwa Securities | Neutral → Outperform |
| 2023-01-26 | Downgrade | UBS | Buy → Neutral |
| 2023-01-17 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2023-01-04 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-12-13 | Aggiornamento | Goldman | Neutral → Buy |
| 2022-11-18 | Iniziato | Credit Suisse | Outperform |
| 2022-05-23 | Iniziato | SVB Leerink | Mkt Perform |
| 2022-04-06 | Ripresa | Morgan Stanley | Equal-Weight |
| 2022-01-05 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2022-01-03 | Reiterato | Bernstein | Mkt Perform |
| 2021-12-20 | Reiterato | Cowen | Outperform |
| 2021-12-17 | Iniziato | Goldman | Neutral |
| 2021-12-13 | Aggiornamento | UBS | Neutral → Buy |
| 2021-12-09 | Iniziato | Wells Fargo | Overweight |
| 2021-11-19 | Iniziato | BMO Capital Markets | Outperform |
| 2021-07-27 | Ripresa | Truist | Buy |
| 2021-05-06 | Downgrade | Mizuho | Buy → Neutral |
| 2021-04-07 | Ripresa | RBC Capital Mkts | Sector Perform |
| 2021-02-04 | Aggiornamento | DZ Bank | Hold → Buy |
| 2020-12-16 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-11-19 | Ripresa | Goldman | Neutral |
| 2020-11-10 | Ripresa | Bernstein | Mkt Perform |
| 2020-10-12 | Downgrade | Atlantic Equities | Overweight → Neutral |
| 2020-09-29 | Iniziato | Berenberg | Hold |
| 2020-06-16 | Iniziato | SVB Leerink | Mkt Perform |
| 2020-02-27 | Iniziato | Barclays | Equal Weight |
| 2020-02-27 | Aggiornamento | Standpoint Research | Hold → Buy |
| 2020-02-06 | Iniziato | Mizuho | Buy |
| 2020-01-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2019-10-17 | Ripresa | BofA/Merrill | Neutral |
| 2019-07-30 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2019-07-30 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2019-06-04 | Ripresa | Morgan Stanley | Overweight |
| 2019-02-20 | Ripresa | Citigroup | Neutral |
| 2019-01-31 | Aggiornamento | Argus | Hold → Buy |
| 2019-01-31 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2019-01-23 | Downgrade | UBS | Buy → Neutral |
| 2018-12-11 | Downgrade | JP Morgan | Overweight → Neutral |
| 2018-11-01 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
Mostra tutto
Pfizer Inc Borsa (PFE) Ultime notizie
Pfizer Advances PF-07248144 With Key Drug-Interaction Study Completion - TipRanks
Pfizer: Patient Investors Will Be Rewarded (NYSE:PFE) - Seeking Alpha
Pharma Stocks Have Rallied. 2 Stocks to Avoid—and 2 to Buy. - Barron's
Mitsubishi UFJ Trust & Banking Corp Grows Position in Pfizer Inc. $PFE - MarketBeat
Pfizer Inc. $PFE Shares Acquired by Russell Investments Group Ltd. - MarketBeat
Pfizer stock holds gains after Q2 2026 earnings beat and guidance raise - Ad-hoc-news.de
Global Retirement Partners LLC Makes New $4.34 Million Investment in Pfizer Inc. $PFE - MarketBeat
Bank of New York Mellon Corp Has $1.39 Billion Position in Pfizer Inc. $PFE - MarketBeat
What Is New for Pfizer (NYSE:PFE) Across Its Oncology Pipeline? - Kalkine Media
Pfizer (PFE) Rides MRNA Cancer Optimism On A Valuation That Still Looks Modest - simplywall.st
PCF-Pfizer Visiting Professorship Program 2026 for Precision Medicine in Prostate Cancer Care - Oncodaily
Pfizer (NYSE:PFE) Shares Down 1.5%Should You Sell? - MarketBeat
Pfizer Stock's Next Chapter Might Be Hiding in Plain Sight - Trefis
Quant MF raises Pfizer stake with Rs 131 cr purchase; Pari Washington buys over 2% in Amrutanjan Health Care - TradingView
Pfizer Stock Is A Race Between New Drugs And Old Patents - Trefis
Pfizer’s Ibrance Real-World Breast Cancer Study Wraps Up: What Investors Should Watch Next - TipRanks
Dividend Giants Pfizer, Chevron, AbbVie: Bold 2027 Price Targets Ahead - 24/7 Wall St.
Pfizer stock hits a fresh 52-week high as Q2 2026 earnings beat and guidance lift support the rally. - Ad-hoc-news.de
KBC Group NV Sells 144,649 Shares of Pfizer Inc. $PFE - MarketBeat
Janney Montgomery Scott LLC Has $58.14 Million Stock Position in Pfizer Inc. $PFE - MarketBeat
Why Is Pfizer (NYSE:PFE) Settling Thousands of Legal Claims? - Kalkine Media
Healthcare Stocks After Hours: Moderna, Merck Cool Following Cancer Trial GainsPfizer (NYSE:PFE), Mode - Benzinga
Pfizer (PFE) Breaks to a 52-Week High at $28.24, Clearing the April Peak - 24/7 Wall St.
Pfizer (PFE) Reaches Deal Covering About 5,000 Federal Lawsuit Claims - simplywall.st
Why Pfizer (PFE) Stock Is Trading Up Today - Yahoo Finance
Pfizer (NYSE:PFE) Shares Up 3.7%Still a Buy? - MarketBeat
A Look at Pfizer Inc (PFE) After 3.6% Gain -- GF Value $26.53 vs Price $28.24 - GuruFocus
PFE Stock Quote Price and Forecast - CNN
Which Drugmaker Stock Has Dominated in 2026: Merck, Pfizer, or Amgen? - 24/7 Wall St.
Pfizer Inc Stock (PFE) Moved Up by 3.96% on Aug 19: What Signal Does It Send? - TradingKey
Merck Just Raised the Stakes for Pfizer's Cancer Vaccine Ambitions - Benzinga
Pfizer Stock Rises Wednesday: What's Going On? - Benzinga
Pfizer's Obesity Push: Can Berobenatide Take Market Share? - Yahoo Finance
Pfizer Inc (PFE): A Closer Look Behind a 68 GF Score - GuruFocus
Insider Watch: 3 CEOs Betting Millions on Their Own Stocks - TradingView
Protalix (PLX) Q2 2026 Earnings Call Transcript - The Motley Fool
Pfizer Shares Gain 1.4% as Insider Acquisition Worth $3 Million Counters Reports of Fund Sales - TechStock²
Pfizer stock holds steady as investors weigh Q2 earnings beat and pipeline updates - Ad-hoc-news.de
Pfizer Inc. $PFE Shares Sold by Heritage Investors Management Corp - MarketBeat
TD Asset Management Inc Has $94.56 Million Stake in Pfizer Inc. $PFE - MarketBeat
Leuthold Group LLC Makes New Investment in Pfizer Inc. $PFE - MarketBeat
111 Capital Takes $3.71 Million Position in Pfizer Inc. $PFE - MarketBeat
Pfizer (NYSE:PFE) Trading Up 1.6%Here's Why - MarketBeat
Pfizer (PFE) Gets EMA Lyme Vaccine Filing Validation As ADC Patent Clout Grows - Yahoo Finance
Pfizer Pick of the Week at Smart Insider Following CEO's First Share Purchase - marketscreener.com
Pfizer: Still Cheap Valuation Meets A Looming Patent Cliff - Seeking Alpha
Pfizer Inc. $PFE Holdings Increased by Willis Investment Counsel - MarketBeat
University of Texas Texas AM Investment Management Co. Invests $3.97 Million in Pfizer Inc. $PFE - MarketBeat
Cornerstone Capital Inc. Grows Position in Pfizer Inc. $PFE - MarketBeat
Can Pfizer (NYSE:PFE) Pipeline Wins Offset Non-Cash Impairment Charges? - Kalkine Media
Albert Bourla Bought 9.6% More Shares In Pfizer - simplywall.st
Pfizer Inc Azioni (PFE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.14%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):